XERS
XERS
NASDAQ · Pharmaceuticals

Xeris Biopharma Holdings Inc

$6.53
-0.10 (-1.51%)
As of May 10, 10:09 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +614.4% upside
Low Target $35.62
Average Target $46.65
High Target $60.75
Current Price $6.53
Current
$6.53
Target
$46.65
$35.62 $46.65 avg $60.75
Scenario Analysis
Bear Case
$35.62
445.5%
Low target
Base Case
$46.65
+614.4%
Avg target
Bull Case
$60.75
+830.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-35.2% from high
52-Week Low
$4.30
+51.9% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%